Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Enzon Pharmaceuticals
(OTCQX:ENZN)
Intraday
$0.0724
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$0.0724
0
[0.00%]
At close: Apr 17
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Enzon Pharmaceuticals Stock (OTC:ENZN)
Enzon Pharmaceuticals Stock (OTC: ENZN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, February 08, 2022
The 2022 OTCQX Best 50 Has Been Announced — Here Are The Companies That Made The Cut
Jad Malaeb
-
Sponsored
Tuesday, November 19, 2019
Stocks That Hit 52-Week Lows On Tuesday
Lisa Levin
-
Nov 19, 2019, 11:28AM
Wednesday, September 25, 2019
Stocks That Hit 52-Week Highs On Wednesday
Lisa Levin
-
Sep 25, 2019, 11:07AM
Saturday, March 04, 2017
Icahn's (Potential) Move Into Biotech
Benzinga
-
Mar 4, 2017, 7:25PM
Thursday, December 08, 2016
Enzon Pharmaceuticals Entered Into Standstill Agreement With Icahn And Affiliates, Pursuant To Agreement, Icahn And Associates Will Not Acquire Any Additional Shares Of Stock
Benzinga
-
Dec 8, 2016, 4:28PM
Tuesday, November 29, 2016
Enzon Pharmaceuticals +22.5% Premarket @ $0.49 as Amended 13D Shows Icahn Raised Stake from 13.29% to 14.92%
Benzinga
-
Nov 29, 2016, 8:44AM
BZ NOTE: Carl Icahn 13F From Quarter Ending In March, Which Was Filed In May, Previously Showed 5.9M Share Stake In Enzon; Today's Filing Shows ~6.6M Share Stake
Benzinga
-
Nov 29, 2016, 8:40AM
UPDATE: Carl Icahn Reports 14.9% Stake In Enzon Pharmaceuticals 13D Filing
Benzinga
-
Nov 29, 2016, 8:27AM
Carl Icahn Filing Out On Enzon Pharmaceuticals
Benzinga
-
Nov 29, 2016, 8:26AM
Monday, May 16, 2016
It's 13F Season: All Of Carl Icahn's Positions
Benzinga
-
May 16, 2016, 6:20PM
Friday, March 18, 2016
Enzon Pharmaceuticals Down Almost 30% YTD
Benzinga
-
Mar 18, 2016, 12:42PM
Thursday, December 03, 2015
Enzon Pharmaceuticals Board Declared Special Cash Dividend Of $0.25/Share on Common Stock -8K
Benzinga
-
Dec 3, 2015, 6:12AM
8-K from Enzon Pharma Shows Board Declared Special Cash Dividend of $0.25/Share
Benzinga
-
Dec 3, 2015, 6:10AM
Thursday, July 02, 2015
5 NASDAQ Healthcare Stocks With The Highest ROA
Benzinga
-
Jul 2, 2015, 9:23AM
Wednesday, June 10, 2015
5 NASDAQ Healthcare Stocks With The Highest Profit Margin
Benzinga
-
Jun 10, 2015, 9:21AM
Wednesday, May 13, 2015
Ichan Holding, Enzon Pharmaceuticals Shares Move Higher, May be Attributed to 10Q Filing
Benzinga
-
May 13, 2015, 9:37AM
Thursday, April 30, 2015
Top 4 Small-Cap Stocks In The Computer Peripherals Industry With The Highest Profit Margin
Benzinga
-
Apr 30, 2015, 4:58AM
Wednesday, April 29, 2015
Top 4 Small-Cap Stocks In The Biotechnology Industry With The Highest Profit Margin
Benzinga
-
Apr 29, 2015, 4:50AM
Thursday, April 16, 2015
Enzon Pharmaceuticals Shares off the High; Shares Moved Higher on Circulation of Link to April 1 Blog Post Mentioning Icahn Stake
Benzinga
-
Apr 16, 2015, 12:23PM
Icahn Stake in Enzon Pharmaceuticals Mentioned in Blog Post
Benzinga
-
Apr 16, 2015, 11:27AM
Monday, March 30, 2015
Top 4 NASDAQ Stocks In The Biotechnology Industry With The Highest Operating Margin
Benzinga
-
Mar 30, 2015, 4:59AM
Monday, February 09, 2015
Top 4 NASDAQ Stocks In The Biotechnology Industry With The Highest Profit Margin
Benzinga
-
Feb 9, 2015, 4:35AM
Friday, December 05, 2014
8-K from Enzon Shows Declaration of $0.10/Share Special Dividend
Benzinga
-
Dec 5, 2014, 4:28PM
Tuesday, September 23, 2014
5 Healthcare Stocks With The Highest Operating Margin
Benzinga
-
Sep 23, 2014, 9:23AM
Thursday, August 21, 2014
Top 4 NASDAQ Stocks In The Biotechnology Industry With The Highest Operating Margin
Benzinga
-
Aug 21, 2014, 4:57AM
Tuesday, June 10, 2014
Enzon Shares Move Higher on Volume; May be Attributed to Street Insider Report from Monday, Being Circulated Now
Benzinga
-
Jun 10, 2014, 10:13AM
Thursday, May 01, 2014
Enzon Adopts Shareholder Rights Plan to Protect Net Operating Loss Carryforwards
Benzinga
-
May 1, 2014, 8:34AM
Thursday, March 13, 2014
Stonepine Capital Reports 9.5% Passive Stake In Enzon Pharmaceuticals as of March 5 -13G
Benzinga
-
Mar 13, 2014, 6:16AM
Wednesday, January 15, 2014
Stocks Hitting 52-Week Lows
Benzinga
-
Jan 15, 2014, 10:22AM
Friday, January 03, 2014
Stocks Hitting 52-Week Lows
Benzinga
-
Jan 3, 2014, 10:18AM
Tuesday, December 24, 2013
Stocks Hitting 52-Week Lows
Benzinga
-
Dec 24, 2013, 10:55AM
Morning Market Losers
Benzinga
-
Dec 24, 2013, 10:04AM
Tuesday, October 22, 2013
Form 8-K from Enzon Pharma Shows Co. Has Terminated License, Collaboration Deal with Santaris, Terms Undisclosed
Benzinga
-
Oct 22, 2013, 4:35PM
Wednesday, October 09, 2013
13D Filing from Icahn on Enzon Pharma Discloses Jonathan Christodoro as Director
Benzinga
-
Oct 9, 2013, 4:42PM
Amended 13D Filing from Carl Icahn on Enzon Pharma
Benzinga
-
Oct 9, 2013, 4:40PM
Tuesday, April 23, 2013
Enzon Pharma Shares to Resume Trading at 4:30PM EDT
Benzinga
-
Apr 23, 2013, 4:26PM
UPDATE: Enzon Reported Concluded Review of Possible Sale of Assets, Authorizes $1.60/Share Special Dividend, Periodic Royalty Dividends
Benzinga
-
Apr 23, 2013, 4:22PM
Enzon Reported Concluded Review of Possible Sale of Assets, Authorizes $1.60/Share Special Dividend, Periodic Royalty Dividends
Benzinga
-
Apr 23, 2013, 4:22PM
Enzon Pharma Halted News PEnding
Benzinga
-
Apr 23, 2013, 4:01PM
Tuesday, March 26, 2013
8-K Filing from Enzon Pharma Shows Co. to Cut Workforce from 19 to 12, Sees $1.3M Charge
Benzinga
-
Mar 26, 2013, 4:35PM
Monday, March 18, 2013
Enzon Pharmaceuticals, Inc. Reports Q4 EPS of $(0.11), Down 22% YOY
Benzinga
-
Mar 18, 2013, 5:10PM
Monday, March 11, 2013
Stocks Hitting 52-Week Lows
Benzinga
-
Mar 11, 2013, 11:17AM
Wednesday, February 13, 2013
13-F Alert: Baupost Group Adds AIG Shares and Microsoft Call Options
Benzinga
-
Feb 13, 2013, 6:16PM
Monday, December 17, 2012
Benzinga's M&A Chatter for Monday December 17, 2012
Benzinga
-
Dec 17, 2012, 5:33PM
Enzon Resumes Trading
Benzinga
-
Dec 17, 2012, 7:35AM
Enzon Pharma Shares Resume
Benzinga
-
Dec 17, 2012, 7:33AM
Enzon Hires Lazard to Review Asset Sales, Sale of the Company
Benzinga
-
Dec 17, 2012, 7:22AM
Enzon Halted
Benzinga
-
Dec 17, 2012, 7:04AM
Thursday, November 29, 2012
Enzon Shares to to Resume Trading at 6PM EST
Benzinga
-
Nov 29, 2012, 5:38PM
Enzon Pharma Declares $2/Share Special Dividend
Benzinga
-
Nov 29, 2012, 5:28PM
Show more